FOXA2 was previously implicated in cell proliferation, cancer stem cell maintenance, and an increase in relapse in triple-negative breast cancer [63], while HNF4A was related to an increase in lymph node and distant metastasis in colon cancer [64,65]. Here, FOXA2 is linked to cancer.